The FDA is seeking feedback on generative-AI medical-device regulation

The US Food and Drug Administration is asking for input on how to regulate generative-AI-enabled medical devices, including continuous learning, output reliability, changing risk and post-market monitoring; developers need auditable model versions, data provenance and human review.